chevron_leftBack
As of 5 June 2026, BioNote, Inc. has a market cap of $337.17M USD, ranking #17867 globally and #566 in South Korea.
It ranks #1620 in the Healthcare sector, and #340 in the Medical Devices industry.
Key Stats
Market Cap
$337.17MUSD
518.29B KRW
Enterprise Value
$118.82MUSD
182.13B KRW
Revenue (TTM)
$76.97MUSD
118.32B KRW
EBITDA (TTM)
$16.99MUSD
26.04B KRW
Net Income (TTM)
-$56.92MUSD
-87.5B KRW
EBITDA Margin
22%
Profit Margin
-74%
PS Ratio
4.4
PB Ratio
0.3
EV/EBITDA
7.0
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Medical Devices
Employees
298
Founded
2003
Website
bionote.co.kr
open_in_new
warningChart data may be delayed
| 1d | 1w | 1m | 3m | 6m | 1y |
|---|---|---|---|---|---|
| -0.2% | 1.6% | -6% | -5.9% | -6.4% | 13% |
News
Loading...
Markets
| Exchange | Ticker | Price |
|---|---|---|
|
377740
㈜바이오노트가 Ordinary Shares
ISIN: KR7377740006
Shares Out.:
Shares Outstanding:
100.913M1
Shares Float:
12.39M2
TV:
TradingView:
SA:
Stock Analysis:
YF:
Yahoo Finance:
GF:
Google Finance:
BA:
Barron's:
MS:
Morningstar:
|
5,120 KRW |
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.
About BioNote, Inc.
BioNote, Inc., manufactures and sells in-vitro diagnostic animal medicines in South Korea. It offers animal diagnostics products, such as fluorescence immunoassay, molecular diagnostics, clinical biochemistry, rapid immunoassay, and enzyme-linked immunosorbent assay products. The company also provides bio-content products, including rapid immunoassay for humans, human intermediate goods, and bio-contents reagents. In addition, it engages in the production and sell of medical devices. BioNote, Inc. was founded in 2003 and is headquartered in Hwaseong-si, South Korea.
Similar Companies
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
KRX: 214150
|
$2.44B
624%
3.75T KRW
|
28.7
|
|
KRX: 458870
|
$1.21B
260%
1.86T KRW
|
114.8
|
|
KRX: 491000
|
$1.18B
249%
1.81T KRW
|
-
|
|
KRX: 290650
|
$1.13B
235%
1.74T KRW
|
-
|
|
KRX: 096530
|
$751.49M
123%
1.16T KRW
|
23.9
|
|
KRX: 214430
|
$526.7M
56%
809.64B KRW
|
83.3
|
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
NYSE: TMO
|
$173.27B
51K%
|
25.8
|
|
NASDAQ: ISRG
|
$160.73B
48K%
|
56.7
|
|
NYSE: ABT
|
$159.07B
47K%
|
25.6
|
|
NYSE: DHR
|
$126.55B
37K%
|
34.7
|
|
NYSE: SYK
|
$120.69B
36K%
|
38.3
|
|
NYSE: MDT
|
$101.9B
30K%
|
22.2
|
chevron_leftBack